| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 生物谷 920266 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.05 | — | — | 80% | 40% | 0.6 | -6.1% | -10% | -3% | -18% | — | — | — | 9 |
| 大唐药业 920433 | 亏损或困境 | 中药Ⅱ | — | — | — | 3.41 | — | 208% | 71% | 69% | — | -0.9% | -5% | -3% | -16% | — | — | — | 13 |
| ST金花 600080 | 亏损或困境 | 中药Ⅱ | 178.0 | — | — | 1.14 | — | 14% | 76% | 32% | 2.3 | -2.0% | -2% | -3% | -36% | -39% | -52% | 37% | 18 |
| ST嘉应 002198 | 中性 | 中药Ⅱ | — | — | — | 2.69 | — | 74% | 65% | 26% | 0.6 | -6.5% | -16% | -4% | -47% | -45% | -65% | 46% | 19 |
| 新天药业 002873 | 中性 | 中药Ⅱ | 250.1 | — | — | 1.61 | 0.3% | 42% | 77% | 34% | 8.1 | 2.8% | -12% | +6% | -15% | -37% | -44% | 34% | 21 |
| 恩威医药 301331 | 纯久期 | 中药Ⅱ | 74.5 | — | — | 2.16 | 4.8% | 65% | 51% | 18% | 2.4 | 2.3% | +9% | +16% | -16% | -44% | -47% | 42% | 22 |
| 古汉医药 000590 | 亏损或困境 | 中药Ⅱ | — | — | — | 4.16 | — | — | 51% | 36% | 6.4 | -3.0% | -1% | +58% | -17% | -24% | -40% | 35% | 22 |
| 新光药业 300519 | 中性 | 中药Ⅱ | 37.0 | — | — | 2.77 | 2.1% | 97% | 41% | 10% | — | 3.9% | -9% | +15% | -2% | -15% | -31% | 38% | 23 |
| 益盛药业 002566 | 纯久期 | 中药Ⅱ | 62.6 | — | — | 1.04 | 1.1% | 64% | 74% | 13% | 6.1 | 4.3% | -8% | +14% | -7% | -15% | -35% | 35% | 23 |
| ST葫芦娃 605199 | 亏损或困境 | 中药Ⅱ | — | — | — | 7.97 | — | 310% | 51% | 57% | — | 5.8% | -16% | -52% | -22% | -36% | -49% | 34% | 24 |
| 华神科技 000790 | 亏损或困境 | 中药Ⅱ | — | — | — | 3.54 | — | 22% | 41% | 41% | — | 1.8% | -14% | -1% | +6% | -3% | -24% | 36% | 26 |
| 天目药业 600671 | 亏损或困境 | 中药Ⅱ | 194.8 | — | — | 34.92 | — | — | 31% | 38% | 3.7 | 1.0% | +25% | +97% | +26% | +10% | -29% | 45% | 27 |
| 益佰制药 600594 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.39 | — | 50% | 70% | 42% | 177.8 | 3.9% | -12% | +12% | -6% | -20% | -42% | 46% | 29 |
| 盘龙药业 002864 | 中性 | 中药Ⅱ | 37.4 | — | — | 1.69 | 1.3% | 26% | 58% | 18% | 0.4 | 5.0% | +5% | +3% | -9% | -9% | -36% | 41% | 29 |
| 寿仙谷 603896 | 亏损或困境 | 中药Ⅱ | — | 26.6 | 1.27 | 1.33 | — | 30% | 83% | 33% | 2.8 | -5.2% | -8% | -7% | -23% | -34% | -42% | 27% | 29 |
| 粤万年青 301111 | 纯久期 | 中药Ⅱ | 608.1 | — | — | 4.83 | 0.2% | 107% | 69% | 5% | 4.0 | -0.0% | +4% | +17% | +19% | +29% | -45% | 73% | 36 |
| 康惠股份 603139 | 亏损或困境 | 中药Ⅱ | — | — | — | 7.27 | — | — | 31% | 48% | — | -3.0% | -1% | +42% | +79% | +51% | -34% | 49% | 39 |
| 沃华医药 002107 | 现金流红利 | 中药Ⅱ | 33.2 | — | — | 5.57 | 3.9% | 203% | 75% | 33% | 0.0 | 3.4% | -7% | +36% | +14% | +3% | -31% | 44% | 39 |
| 陇神戎发 300534 | 中性 | 中药Ⅱ | 115.9 | — | — | 5.59 | 0.3% | 28% | 64% | 39% | 1.0 | 0.3% | +29% | +10% | +40% | +21% | -36% | 64% | 40 |
| 健民集团 600976 | 轻资产现金牛 | 中药Ⅱ | 13.6 | 11.0 | 0.61 | 1.60 | 3.2% | 38% | 46% | 14% | 0.3 | 5.1% | -2% | -18% | -14% | -31% | -41% | 28% | 43 |
| *ST香雪 300147 | 亏损或困境 | 中药Ⅱ | — | — | — | — | — | — | 26% | 53% | 11.3 | 1.6% | -10% | -7% | -28% | -37% | -47% | 50% | 43 |
| 佛慈制药 002644 | 中性 | 中药Ⅱ | 73.9 | — | — | 2.34 | 0.2% | 21% | 31% | 37% | 0.2 | 6.7% | -4% | +12% | -1% | -9% | -32% | 32% | 44 |
| 特一药业 002728 | 中性 | 中药Ⅱ | 61.6 | — | — | 2.59 | 1.7% | 94% | 53% | 30% | 2.9 | 2.4% | +1% | +22% | -16% | -3% | -47% | 52% | 46 |
| 亚宝药业 600351 | 现金流红利 | 中药Ⅱ | 14.3 | — | — | 1.63 | 8.3% | 76% | 56% | 31% | 0.1 | 12.3% | -6% | +13% | +12% | -2% | -18% | 28% | 46 |
| 方盛制药 603998 | 现金流红利 | 中药Ⅱ | 14.2 | 13.0 | 0.65 | 2.67 | 4.2% | 64% | 68% | 36% | 0.7 | 9.1% | -1% | +13% | -1% | -11% | -30% | 33% | 47 |
| 太龙药业 600222 | 纯久期 | 中药Ⅱ | 90.3 | — | — | 2.95 | 0.2% | 22% | 27% | 12% | 6.6 | 1.7% | -4% | +29% | +30% | +24% | -26% | 48% | 48 |
| 维康药业 300878 | 亏损或困境 | 中药Ⅱ | — | — | — | 5.47 | — | — | 50% | 58% | — | -1.2% | -25% | +71% | +31% | +48% | -34% | 72% | 49 |
| 汉森制药 002412 | 现金流红利 | 中药Ⅱ | 20.6 | — | — | 2.08 | 3.1% | 76% | 73% | 18% | 0.0 | 3.6% | +4% | +7% | +58% | +45% | -31% | 49% | 49 |
| 三力制药 603439 | 定价权·品牌 | 中药Ⅱ | 13198.2 | — | — | 3.37 | 0.5% | 51% | 70% | 18% | 2.8 | 4.6% | +12% | -8% | +5% | -6% | -43% | 38% | 49 |
| 珍宝岛 603567 | 亏损或困境 | 中药Ⅱ | — | — | — | 0.86 | — | 36% | 33% | 13% | — | 8.6% | -43% | -22% | -38% | -56% | -66% | 52% | 52 |
| 振东制药 300158 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.61 | — | — | 50% | 26% | — | -10.5% | -9% | +34% | -9% | -41% | -52% | 46% | 52 |
| 上海凯宝 300039 | 中性 | 中药Ⅱ | 21.7 | — | — | 1.31 | 2.4% | 32% | 80% | 6% | 0.0 | 2.9% | +1% | -0% | -9% | -20% | -37% | 42% | 56 |
| ST万邦 002082 | 亏损或困境 | 中药Ⅱ | — | — | — | 2.20 | — | 100% | 42% | 34% | 13.9 | 8.7% | -14% | +117% | -34% | +17% | -75% | 64% | 57 |
| 信邦制药 002390 | 中性 | 中药Ⅱ | 51.8 | — | — | 0.86 | 2.9% | 120% | 19% | 27% | 1.0 | 14.7% | -4% | -29% | -5% | -18% | -36% | 34% | 58 |
| 华森制药 002907 | 中性 | 中药Ⅱ | 81.6 | — | — | 3.48 | 0.5% | 48% | 57% | 23% | 0.2 | 1.0% | +2% | +15% | -2% | -21% | -36% | 39% | 61 |
| 精华制药 002349 | 中性 | 中药Ⅱ | 28.3 | — | — | 2.25 | 1.2% | 30% | 49% | 15% | 0.0 | 4.7% | -2% | -4% | +7% | -1% | -26% | 32% | 64 |
| ST百灵 002424 | 亏损或困境 | 中药Ⅱ | — | — | — | 2.01 | — | — | 58% | 22% | 4.0 | 7.1% | -5% | +13% | +6% | -27% | -34% | 34% | 64 |
| 昆药集团 600422 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.32 | 2.1% | 35% | 42% | 10% | — | -8.6% | -7% | -20% | -31% | -41% | -49% | 28% | 64 |
| 千金药业 600479 | 成长兑现 | 中药Ⅱ | 19.1 | 17.1 | 1.07 | 2.14 | 2.9% | 57% | 46% | 11% | 0.3 | 7.1% | -3% | -2% | +34% | +20% | -18% | 33% | 65 |
| 广誉远 600771 | 亏损或困境 | 中药Ⅱ | 94.9 | 57.2 | 1.73 | 4.03 | — | — | 68% | 22% | 0.3 | 3.4% | +7% | -5% | -24% | -36% | -40% | 26% | 67 |
| 葵花药业 002737 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.76 | 1.7% | 69% | 56% | 22% | — | 1.8% | -23% | -26% | -19% | -27% | -32% | 26% | 69 |
| 中恒集团 600252 | 亏损或困境 | 中药Ⅱ | — | — | — | 1.35 | — | 41% | 59% | 13% | — | 0.6% | -14% | +11% | -19% | -23% | -42% | 34% | 71 |
| 康缘药业 600557 | 中性 | 中药Ⅱ | 23.0 | 20.3 | 1.69 | 1.43 | — | 80% | 72% | 45% | 0.0 | -0.8% | -9% | +4% | -11% | -34% | -42% | 31% | 71 |
| 桂林三金 002275 | 现金流红利 | 中药Ⅱ | 17.8 | 15.8 | 1.58 | 2.22 | 4.0% | 68% | 73% | 26% | 0.5 | 6.4% | +1% | -3% | -10% | -18% | -20% | 21% | 73 |
| 仁和药业 000650 | 中性 | 中药Ⅱ | 19.1 | — | — | 1.16 | 2.8% | 49% | 37% | 16% | 0.0 | 9.3% | -12% | +1% | -2% | -17% | -26% | 24% | 75 |
| 太极集团 600129 | 中性 | 中药Ⅱ | 109.3 | 24.4 | 0.49 | 2.12 | — | 20% | 42% | 37% | 6.6 | -2.5% | -9% | -27% | -24% | -42% | -50% | 38% | 76 |
| 九芝堂 000989 | 现金流红利 | 中药Ⅱ | 23.2 | 25.2 | 1.26 | 2.08 | 3.3% | 115% | 59% | 22% | 0.1 | 8.1% | -10% | +14% | +6% | -28% | -37% | 34% | 76 |
| 佐力药业 300181 | 中性 | 中药Ⅱ | 14.9 | 12.1 | 0.50 | 2.84 | 2.6% | 82% | 68% | 28% | 0.9 | 1.5% | +19% | +10% | -15% | -31% | -34% | 31% | 94 |
| 红日药业 300026 | 中性 | 中药Ⅱ | 552.2 | — | — | 1.16 | 0.3% | 100% | 58% | 26% | 0.7 | 6.9% | -9% | -6% | -6% | -23% | -32% | 28% | 99 |
| 马应龙 600993 | 轻资产现金牛 | 中药Ⅱ | 16.5 | 14.9 | 1.15 | 2.24 | 3.0% | 50% | 42% | 11% | 0.1 | 6.4% | +3% | +10% | -16% | -17% | -29% | 23% | 99 |
| 羚锐制药 600285 | 定价权·品牌 | 中药Ⅱ | 14.3 | 13.2 | 1.10 | 3.44 | 5.6% | 79% | 74% | 12% | 0.4 | 7.8% | +9% | -3% | +0% | -13% | -17% | 23% | 111 |
| 康恩贝 600572 | 现金流红利 | 中药Ⅱ | 22.4 | 18.3 | 0.87 | 1.58 | 3.4% | 79% | 58% | 27% | 0.1 | 8.7% | +3% | -1% | +2% | -3% | -19% | 26% | 111 |
| 奇正藏药 002287 | 定价权·品牌 | 中药Ⅱ | 17.2 | — | — | 2.23 | 3.1% | 53% | 84% | 25% | 1.1 | 2.8% | +6% | +15% | -14% | -31% | -34% | 24% | 114 |
| 华润江中 600750 | 定价权·品牌 | 中药Ⅱ | 17.0 | 15.3 | 1.39 | 3.76 | 5.9% | 96% | 65% | 29% | 0.0 | 5.0% | +3% | +8% | +5% | +12% | -19% | 28% | 149 |
| 步长制药 603858 | 现金流红利 | 中药Ⅱ | 66.5 | — | — | 1.56 | 3.8% | 105% | 68% | 24% | 2.5 | 2.2% | -7% | +2% | -4% | -20% | -27% | 27% | 157 |
| 康美药业 600518 | 中性 | 中药Ⅱ | 647.8 | — | — | 2.61 | — | — | 16% | 25% | 0.6 | 0.1% | +8% | -18% | -28% | -35% | -46% | 27% | 191 |
| 众生药业 002317 | 纯久期 | 中药Ⅱ | 105.1 | 73.3 | 3.67 | 5.23 | 0.8% | 62% | 59% | 15% | 0.3 | 2.3% | -2% | +60% | +31% | +7% | -37% | 57% | 209 |
| 天士力 600535 | 中性 | 中药Ⅱ | 18.0 | 17.3 | 1.33 | 1.68 | 2.1% | 46% | 67% | 22% | 0.3 | 7.0% | -1% | +7% | -2% | -12% | -22% | 21% | 220 |
| 吉林敖东 000623 | 中性 | 中药Ⅱ | 7.0 | — | — | 0.69 | 2.7% | 38% | 49% | 6% | 18.9 | 1.0% | -7% | +17% | -4% | -8% | -25% | 28% | 221 |
| 济川药业 600566 | 定价权·品牌 | 中药Ⅱ | 12.9 | 13.1 | 1.64 | 1.72 | 6.7% | 76% | 82% | 14% | 0.7 | 3.4% | -12% | -3% | +5% | +4% | -18% | 29% | 237 |
| 以岭药业 002603 | 现金流红利 | 中药Ⅱ | 19.3 | 17.6 | 1.10 | 2.43 | 5.0% | 70% | 64% | 48% | 0.0 | 7.0% | -14% | +9% | -4% | +2% | -29% | 34% | 265 |
| 达仁堂 600329 | 现金流红利 | 中药Ⅱ | 32.7 | 25.5 | 1.50 | 4.66 | 13.3% | 100% | 44% | 10% | 0.1 | 2.5% | -16% | +65% | -12% | -12% | -27% | 32% | 277 |
| 东阿阿胶 000423 | 现金流红利 | 中药Ⅱ | 17.4 | 15.8 | 1.13 | 3.06 | 5.7% | 100% | 70% | 15% | 0.0 | 3.6% | +18% | -19% | +5% | +0% | -23% | 24% | 311 |
| 白云山 600332 | 现金流红利 | 中药Ⅱ | 12.8 | 10.6 | 1.77 | 0.84 | 4.2% | 46% | 19% | 9% | 5.0 | 5.0% | +3% | -7% | -20% | -24% | -27% | 17% | 329 |
| 同仁堂 600085 | 轻资产现金牛 | 中药Ⅱ | 34.1 | 25.3 | 1.95 | 2.43 | 2.1% | 58% | 47% | 13% | 1.3 | 6.5% | +4% | -20% | -24% | -35% | -40% | 21% | 331 |
| 华润三九 000999 | 定价权·品牌 | 中药Ⅱ | 12.6 | 11.4 | 1.04 | 1.81 | 4.2% | 50% | 54% | 19% | 0.7 | 9.0% | +20% | -15% | -11% | -17% | -26% | 21% | 414 |
| 片仔癀 600436 | 中性 | 中药Ⅱ | 41.3 | 34.7 | 2.04 | 5.11 | 2.4% | 83% | 46% | 10% | 0.5 | 1.0% | +1% | -20% | -26% | -41% | -49% | 29% | 747 |
| 云南白药 000538 | 现金流红利 | 中药Ⅱ | 17.4 | 16.4 | 2.05 | 2.22 | 5.1% | 90% | 27% | 8% | 0.1 | 4.7% | +4% | -2% | -8% | -8% | -18% | 14% | 910 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。